Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Rosell

Showing results (241-250 of 470) with videos related to

Pageof 47
Sort By:
Oncology Letters|April 30, 2017
High BIM mRNA levels are associated with longer survival in advanced gastric cancerNandie Wu, Ying Huang, Zhengyun Zou, et al.
Translational Lung Cancer Research|March 15, 2021
TIPE3 promotes non-small cell lung cancer progression via the protein kinase B/extracellular signal-regulated kinase 1/2-glycogen synthase kinase 3β-β-catenin/Snail axisQiang Li, Dongmei Yu, Zhengyuan Yu, et al.
Clinical Lung Cancer|July 23, 2013
Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genesMarcin Skrzypski, Rafał Dziadziuszko, Ewa Jassem, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevanceGerold Bepler, Zhong Zheng, Ashish Gautam, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2013
Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITAStephen L Graziano, Benjamin Lacas, Robin Vollmer, et al.
Oncotarget|November 8, 2013
The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapyLaura Bonanno, Carlota Costa, Margarita Majem, et al.
Clinical Lung Cancer|February 4, 2014
Treatment of advanced non-small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation or ALK gene rearrangement: results of an international expert panel meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Filippo de Marinis, Federico Cappuzzo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2011
Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancerRafael Sirera, Roy M Bremnes, Andrea Cabrera, et al.
Expert Review of Respiratory Medicine|August 15, 2019
Characterising acquired resistance to erlotinib in non-small cell lung cancer patientsNiki Karachaliou, Jordi Codony-Servat, Jillian Wilhelmina Paulina Bracht, et al.
Oncotarget|May 19, 2017
Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC)Carles Codony-Servat, Jordi Codony-Servat, Niki Karachaliou, et al.
Pageof 47

Showing results (241-250 of 470) with videos related to

Sort By:
Pageof 47
Oncology Letters|April 30, 2017
High BIM mRNA levels are associated with longer survival in advanced gastric cancerNandie Wu, Ying Huang, Zhengyun Zou, et al.
Translational Lung Cancer Research|March 15, 2021
TIPE3 promotes non-small cell lung cancer progression via the protein kinase B/extracellular signal-regulated kinase 1/2-glycogen synthase kinase 3β-β-catenin/Snail axisQiang Li, Dongmei Yu, Zhengyuan Yu, et al.
Clinical Lung Cancer|July 23, 2013
Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genesMarcin Skrzypski, Rafał Dziadziuszko, Ewa Jassem, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevanceGerold Bepler, Zhong Zheng, Ashish Gautam, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2013
Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITAStephen L Graziano, Benjamin Lacas, Robin Vollmer, et al.
Oncotarget|November 8, 2013
The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapyLaura Bonanno, Carlota Costa, Margarita Majem, et al.
Clinical Lung Cancer|February 4, 2014
Treatment of advanced non-small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation or ALK gene rearrangement: results of an international expert panel meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Filippo de Marinis, Federico Cappuzzo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2011
Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancerRafael Sirera, Roy M Bremnes, Andrea Cabrera, et al.
Expert Review of Respiratory Medicine|August 15, 2019
Characterising acquired resistance to erlotinib in non-small cell lung cancer patientsNiki Karachaliou, Jordi Codony-Servat, Jillian Wilhelmina Paulina Bracht, et al.
Oncotarget|May 19, 2017
Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC)Carles Codony-Servat, Jordi Codony-Servat, Niki Karachaliou, et al.
Pageof 47